Pharmaceutical production grew globally over the last decades: active ingredients and finished products are manufactured across different regions, and circulate through multiple distribution channels. Sadly, Continue Reading
“Public health” oriented licenses and patent pooling in Africa promotes research and production of affordable, high quality generic treatments for AIDS, hepatitis C and tuberculosis. The United Nations Continue Reading
In Sub-Saharan Africa, integrated technology-enabled distribution networks can increase access, enhance quality and lower the prices of medicines. Sub-Saharan Africa’s pharmaceutical market represents a huge Continue Reading
With 13% of the world’s population and 24% of the global burden of disease – but 6% of health expenditure and only 3% of the world’s pharmaceutical output, Africa faces […]Continue Reading
